Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot_老虎社区_美港股上老虎

Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot

Tiger Newspress2021-10-26

Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.

“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.

Ocugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

夜行星
·2021-10-28
Nice
回复
点赞
举报
Never ever f
·2021-10-27
Great
回复
点赞
举报
EsmeT
·2021-10-26
🤔
回复
1
举报
收起
- EsmeT:
  🤔
  2021-10-26
  回复
  举报
DylanX
·2021-10-26
It will moon by end Oct
回复
2
举报
收起
- Never ever f:
  Like
  2021-10-27
  回复
  举报
JTSwee
·2021-10-26
Ok
回复
1
举报
收起
- JTSwee:
  One comment one like tO the moon
  2021-10-26
  回复
  举报
SFern
·2021-10-26
Good
回复
2
举报
收起
- xnubx:
  confirmation out already?
  2021-10-26
  回复
  举报
- SFern:
  Lol
  2021-10-26
  回复
  举报
SFern
·2021-10-26
Good
回复
1
举报
收起
- Veldora:
  [666]
  2021-10-26
  回复
  举报
BBBBBBBBBB
·2021-10-26
Ok
回复
2
举报
keldy2114
·2021-10-26
55555555
回复
3
举报
WCH123
·2021-10-26
Ok
回复
3
举报
CLOUD1127
·2021-10-26
Ok
回复
3
举报
收起
- whoartthou:
  c
  2021-10-26
  回复
  举报
synsher
·2021-10-26
Please like thank you so much
回复
6
举报
Jimmyboy
·2021-10-26
Pls like
回复
7
举报
收起
- Shhui:
  Liked
  2021-10-26
  回复
  举报
Gold75
·2021-10-26
Pls give me a like…tq
回复
8
举报
收起
- xJimmy:
  ok
  2021-10-26
  回复
  举报
ApeKit
·2021-10-26
Liked
回复
6
举报
收起
- Zhenghao:
  Ok
  2021-10-26
  回复
  举报
- Han96:
  Liked
  2021-10-26
  回复
  举报
- Gyon888:
  like
  2021-10-26
  回复
  举报
一初心一
·2021-10-26
Please like, thanks
回复
6
举报
收起
- S土豪熊貓G:
  莫忘
  2021-10-26
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1110933668?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-10-26 21:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110933668","market":"us","top_or_hot":-1,"title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","media":"Tiger Newspress","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n2021-10-26 21:35 北京时间&nbsp;&nbsp;&nbsp;<strong>Tiger Newspress</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of ...</p>\n\n<a href=\"None\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OCGN","symbol_name":"Ocugen","start_time":0,"source_url":null,"article_id":"1110933668","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","pubTimestamp":1635255312,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OCGN":"Ocugen"},"translate_title":"由于世界卫生组织就其合作伙伴的新冠肺炎投篮举行了会议，Ocugen在早盘交易中飙升超过20%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OCGN":0.9},"content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":855738689,"gmtCreate":1635399737179,"gmtModify":1635399737693,"author":{"id":"3582285484477860","authorId":"3582285484477860","name":"夜行星","avatar":"https://static.tigerbbs.com/b30382b13e00165eba468359762783aa","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3582285484477860","idStr":"3582285484477860"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/855738689","repostId":1110933668,"repostType":2,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":852263371,"gmtCreate":1635283388661,"gmtModify":1635283389717,"author":{"id":"3555043402922696","authorId":"3555043402922696","name":"Never ever f","avatar":"https://static.tigerbbs.com/52501d43721648c944a019db9c767c5d","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3555043402922696","idStr":"3555043402922696"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852263371","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":852628966,"gmtCreate":1635263326358,"gmtModify":1635263385949,"author":{"id":"3583324925442360","authorId":"3583324925442360","name":"EsmeT","avatar":"https://static.tigerbbs.com/2de5124e6af354a5501487b248f6a83b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3583324925442360","idStr":"3583324925442360"},"htmlText":"🤔","listText":"🤔","text":"🤔","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852628966","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6335144,"gmtCreate":1635263342044,"gmtModify":1635263342082,"authorId":3583324925442360,"author":{"id":3583324925442360,"idStr":"3583324925442360","authorId":3583324925442360,"name":"EsmeT","avatar":"https://static.tigerbbs.com/2de5124e6af354a5501487b248f6a83b","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852628966,"type":1,"supId":0,"prevId":0,"content":"🤔","text":"🤔","html":"🤔"}],"langContent":"CN"},{"id":852662164,"gmtCreate":1635262658836,"gmtModify":1635262658940,"author":{"id":"3554723558168801","authorId":"3554723558168801","name":"DylanX","avatar":"https://static.tigerbbs.com/07b8db5e79f296265b4f663f3af65aaf","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3554723558168801","idStr":"3554723558168801"},"htmlText":"It will moon by end Oct","listText":"It will moon by end Oct","text":"It will moon by end Oct","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852662164","repostId":1110933668,"repostType":2,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6336182,"gmtCreate":1635283396653,"gmtModify":1635283396688,"authorId":3555043402922696,"author":{"id":3555043402922696,"idStr":"3555043402922696","authorId":3555043402922696,"name":"Never ever f","avatar":"https://static.tigerbbs.com/52501d43721648c944a019db9c767c5d","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852662164,"type":1,"supId":0,"prevId":0,"content":"Like","text":"Like","html":"Like"}],"langContent":"CN"},{"id":852638752,"gmtCreate":1635260999785,"gmtModify":1635261000135,"author":{"id":"3573476245919967","authorId":"3573476245919967","name":"JTSwee","avatar":"https://static.tigerbbs.com/d89d54bc6d3caf822326997927047f4b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3573476245919967","idStr":"3573476245919967"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852638752","repostId":1110933668,"repostType":2,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6334636,"gmtCreate":1635261012072,"gmtModify":1635261012182,"authorId":3573476245919967,"author":{"id":3573476245919967,"idStr":"3573476245919967","authorId":3573476245919967,"name":"JTSwee","avatar":"https://static.tigerbbs.com/d89d54bc6d3caf822326997927047f4b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852638752,"type":1,"supId":0,"prevId":0,"content":"One comment one like tO the moon","text":"One comment one like tO the moon","html":"One comment one like tO the moon"}],"langContent":"CN"},{"id":852871726,"gmtCreate":1635259257073,"gmtModify":1635259416963,"author":{"id":"3582938826092533","authorId":"3582938826092533","name":"SFern","avatar":"https://static.tigerbbs.com/81a61c88544234a53cc63054a8f769b1","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3582938826092533","idStr":"3582938826092533"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/852871726","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6334314,"gmtCreate":1635259493203,"gmtModify":1635259493334,"authorId":3561423443372929,"author":{"id":3561423443372929,"idStr":"3561423443372929","authorId":3561423443372929,"name":"xnubx","avatar":"https://static.tigerbbs.com/6f39797fc5c6bba66d7252326b6668d5","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852871726,"type":1,"supId":0,"prevId":0,"content":"confirmation out already?","text":"confirmation out already?","html":"confirmation out already?"},{"id":6334251,"gmtCreate":1635259275991,"gmtModify":1635259276021,"authorId":3582938826092533,"author":{"id":3582938826092533,"idStr":"3582938826092533","authorId":3582938826092533,"name":"SFern","avatar":"https://static.tigerbbs.com/81a61c88544234a53cc63054a8f769b1","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852871726,"type":1,"supId":0,"prevId":0,"content":"Lol","text":"Lol","html":"Lol"}],"langContent":"CN"},{"id":852871219,"gmtCreate":1635259248274,"gmtModify":1635259409081,"author":{"id":"3582938826092533","authorId":"3582938826092533","name":"SFern","avatar":"https://static.tigerbbs.com/81a61c88544234a53cc63054a8f769b1","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3582938826092533","idStr":"3582938826092533"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852871219","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6334256,"gmtCreate":1635259307578,"gmtModify":1635259307613,"authorId":3580473686930895,"author":{"id":3580473686930895,"idStr":"3580473686930895","authorId":3580473686930895,"name":"Veldora","avatar":"https://static.tigerbbs.com/2c60768e017f3418615cd7dea3a291ec","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852871219,"type":1,"supId":0,"prevId":0,"content":"[666]","text":"[666]","html":"[666]"}],"langContent":"CN"},{"id":852857573,"gmtCreate":1635258706032,"gmtModify":1635258718133,"author":{"id":"3581562365927542","authorId":"3581562365927542","name":"BBBBBBBBBB","avatar":"https://static.tigerbbs.com/973395458d7e1db24dbd4a689c79e8a2","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3581562365927542","idStr":"3581562365927542"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852857573","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":852834589,"gmtCreate":1635256741477,"gmtModify":1635257085346,"author":{"id":"3578437900701319","authorId":"3578437900701319","name":"keldy2114","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3578437900701319","idStr":"3578437900701319"},"htmlText":"55555555","listText":"55555555","text":"55555555","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852834589","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":852834013,"gmtCreate":1635256716572,"gmtModify":1635257047117,"author":{"id":"3569470728297142","authorId":"3569470728297142","name":"WCH123","avatar":"https://static.tigerbbs.com/e9302ce4db718a9febef733d81f0b900","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3569470728297142","idStr":"3569470728297142"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852834013","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":852890027,"gmtCreate":1635256209401,"gmtModify":1635256228873,"author":{"id":"3584019054184037","authorId":"3584019054184037","name":"CLOUD1127","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3584019054184037","idStr":"3584019054184037"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852890027","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6333733,"gmtCreate":1635257454416,"gmtModify":1635257454462,"authorId":3581653518216493,"author":{"id":3581653518216493,"idStr":"3581653518216493","authorId":3581653518216493,"name":"whoartthou","avatar":"https://static.tigerbbs.com/255e220c4fd45d829d979119233c8196","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852890027,"type":1,"supId":0,"prevId":0,"content":"<u>c</u>","text":"<u>c</u>","html":"<u>c</u>"}],"langContent":"CN"},{"id":852174908,"gmtCreate":1635255938507,"gmtModify":1635255988515,"author":{"id":"4087381046304910","authorId":"4087381046304910","name":"synsher","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"4087381046304910","idStr":"4087381046304910"},"htmlText":"Please like thank you so much","listText":"Please like thank you so much","text":"Please like thank you so much","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/852174908","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":852172294,"gmtCreate":1635255916260,"gmtModify":1635255985518,"author":{"id":"3582072891665879","authorId":"3582072891665879","name":"Jimmyboy","avatar":"https://static.tigerbbs.com/cb9d5d497bceb3edaca216e9eeab3c22","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3582072891665879","idStr":"3582072891665879"},"htmlText":"Pls like","listText":"Pls like","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852172294","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6333818,"gmtCreate":1635257839535,"gmtModify":1635257839644,"authorId":4087129674670520,"author":{"id":4087129674670520,"idStr":"4087129674670520","authorId":4087129674670520,"name":"Shhui","avatar":"https://static.tigerbbs.com/a5f0d746b07cd5c1b600923db7d51578","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852172294,"type":1,"supId":0,"prevId":0,"content":"Liked","text":"Liked","html":"Liked"}],"langContent":"CN"},{"id":852147149,"gmtCreate":1635255662396,"gmtModify":1635255663129,"author":{"id":"3576993112269247","authorId":"3576993112269247","name":"Gold75","avatar":"https://static.tigerbbs.com/3e12eb0f20c1c6eecc3de5d5be4a1184","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3576993112269247","idStr":"3576993112269247"},"htmlText":"Pls give me a like…tq","listText":"Pls give me a like…tq","text":"Pls give me a like…tq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852147149","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6333266,"gmtCreate":1635255847445,"gmtModify":1635255847554,"authorId":3570511255316785,"author":{"id":3570511255316785,"idStr":"3570511255316785","authorId":3570511255316785,"name":"xJimmy","avatar":"https://static.tigerbbs.com/b24d4b1856cd8d6958f25fff0e8a85b6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852147149,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":852142907,"gmtCreate":1635255589835,"gmtModify":1635255590177,"author":{"id":"4088233461039020","authorId":"4088233461039020","name":"ApeKit","avatar":"https://static.tigerbbs.com/59e785b685e10955e1dfde832d14ddc1","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"4088233461039020","idStr":"4088233461039020"},"htmlText":"Liked","listText":"Liked","text":"Liked","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/852142907","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6333273,"gmtCreate":1635255883658,"gmtModify":1635255883763,"authorId":3577189579318003,"author":{"id":3577189579318003,"idStr":"3577189579318003","authorId":3577189579318003,"name":"Zhenghao","avatar":"https://static.tigerbbs.com/9bc02f1c85fb8e61dbc393ac0ad551db","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852142907,"type":1,"supId":0,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":6333235,"gmtCreate":1635255642349,"gmtModify":1635255642478,"authorId":3569371789291180,"author":{"id":3569371789291180,"idStr":"3569371789291180","authorId":3569371789291180,"name":"Han96","avatar":"https://static.tigerbbs.com/f97b8f049cf05e776dde087d8f933617","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852142907,"type":1,"supId":0,"prevId":0,"content":"Liked","text":"Liked","html":"Liked"},{"id":6333227,"gmtCreate":1635255605411,"gmtModify":1635255605449,"authorId":3586251975176325,"author":{"id":3586251975176325,"idStr":"3586251975176325","authorId":3586251975176325,"name":"Gyon888","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852142907,"type":1,"supId":0,"prevId":0,"content":"like","text":"like","html":"like"}],"langContent":"CN"},{"id":852141785,"gmtCreate":1635255527715,"gmtModify":1635255528104,"author":{"id":"3579259159683278","authorId":"3579259159683278","name":"一初心一","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"authorIdStr":"3579259159683278","idStr":"3579259159683278"},"htmlText":"Please like, thanks&nbsp;","listText":"Please like, thanks&nbsp;","text":"Please like, thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/852141785","repostId":1110933668,"repostType":4,"repost":{"id":"1110933668","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1635255312,"share":"https://www.laohu8.com/m/news/1110933668?lang=&edition=full","pubTime":"2021-10-26 21:35","market":"us","language":"en","title":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot","url":"https://stock-news.laohu8.com/highlight/detail?id=1110933668","media":"Tiger Newspress","summary":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WH","content":"<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-26 21:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Ocugen soared over 20% in morning trading because of WHO’s&nbsp;meeting on its partner’s COVID-19 shot.<img src=\"https://static.tigerbbs.com/451373be40f4fe6f0e08dacaa59f21b8\" tg-width=\"765\" tg-height=\"558\" width=\"100%\" height=\"auto\">WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.</p>\n<p>“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th&nbsp;to consider EUL for Covaxin,”WHO Chief Scientist&nbsp;Soumya Swaminathan&nbsp;said on Twitter recently.</p>\n<p>Ocugen&nbsp;cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1110933668","content_text":"Ocugen soared over 20% in morning trading because of WHO’s meeting on its partner’s COVID-19 shot.WHO will make a decision on the vaccine developed by Bharat Biotech based on the recommendations of the Technical Advisory Group today.\n“WHO has been working closely with Bharat Biotech to complete the dossier. The technical advisory group will meet on Oct 26th to consider EUL for Covaxin,”WHO Chief Scientist Soumya Swaminathan said on Twitter recently.\nOcugen cooperated with Bharat Biotech for the commercialization of Covaxin in the United States and Canada.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":6333216,"gmtCreate":1635255580968,"gmtModify":1635255580999,"authorId":3578811676095048,"author":{"id":3578811676095048,"idStr":"3578811676095048","authorId":3578811676095048,"name":"S土豪熊貓G","avatar":"https://static.tigerbbs.com/2bf36dcb8e5b590c1e5f4df466413275","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":852141785,"type":1,"supId":0,"prevId":0,"content":"莫忘","text":"莫忘","html":"莫忘"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":93,"commentSize":16,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}